The present invention relates to a naturally occurring, minimally modified LDL antigen which is present in human atherosclerotic lesions as well as in the serum of a high percentage of patients with coronary artery disease. The invention also comprises antibodies reactive with the antigen, hybridoma cell lines that produce the antibodies of the invention, and methods for using the antibodies in the diagnosis and treatment of atherosclerotic disease.
本发明涉及一种天然存在的、最小修饰的低密度脂蛋白抗原,该抗原存在于人类动脉粥样硬化病变以及高比例冠状动脉疾病患者的血清中。本发明还包括与该抗原反应的
抗体、产生本发明
抗体的杂交瘤
细胞系,以及使用该
抗体诊断和治疗动脉粥样硬化疾病的方法。